Posted in | News | Microscopy

CRi's Multispectral Imaging System Recognized as a "Top Ten Medical Innovation"

Cambridge Research + Instrumentation, Inc. (CRi) announced today that the technology of multispectral imaging was ranked as a Top Ten Medical Innovation at Cleveland Clinic's 6th Annual Medical Innovations Summit.

During the recognition presentation, Dr. Jennifer Hunt, head of surgical pathology at the Cleveland Clinic stated, "When we're talking about tumors, we're talking about what information can we gain about that tumor to guide and direct therapy, prognosis, diagnostics. We believe this technology to be a game changer. It will take personalized medicine to an entirely new level. This is not a step, but a leap. Being able to analyze multiple markers in a single cell to understand the behavior of actual signaling pathways will significantly aid in disease diagnosis and therapy development." Dr. Hunt went on to add, "I expect that this technology will be rapidly adopted across the field of pathology." Read more

LOT represent CRi in the UK & Ireland. For more details please go to http://www.lot-oriel.com/site/pages_uk_en/products/nuance/nuance.php.

The Nuance system offers CRi's patented multispectral imaging capabilities at the subcellular, cellular and tissue level. Nuance systems can be easily added onto existing brightfield and fluorescence microscopes with a simple c-mount connection, and are affordable for research labs.

For more information please contact Roslyn Lloyd on 01372 378822, e-mail [email protected]

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.